[ L’utilité de la troponine chez les patients atteints de la COVID19: Preuves d’une méta-analyse ]
Volume 39, Issue 3, May 2023, Pages 1340–1346
Hilmi Chorouk1, Kadouri Souhaila2, Asmaa Morjan3, and Kamal Nbiha4
1 Laboratoire de biochimie, CHU Ibn Rochd de Casablanca, Morocco
2 Laboratoire de biochimie, CHU Ibn Rochd de Casablanca, Morocco
3 Laboratoire de biochimie, CHU Ibn Rochd, Casablanca, Morocco
4 Laboratoire de biochimie, CHU Ibn Rochd de Casablanca, Morocco
Original language: French
Copyright © 2023 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
In December 2019 an infection with a new virus called SARS-COV2 emerged the Wuhan area in China and took the name of COVID-19 (Corona Virus Disease 2019). This disease has spread globally to the point of being called a pandemic by the WHO. Although mainly respiratory in nature, COVID-19 seems to trigger an intense inflammatory response, with a multi-systemic impact including the cardiovascular system. In this work, we propose to synthesize and analyze data from the literature to determine the usefulness of troponin measurement in patients with COVID-19. Cardiac troponin is a laboratory parameter and its measurement is relevant in the management of Covid-19 given the frequency of associated cardiovascular lesions. Several observational studies have shown that patients with Covid-19 have significant elevation of troponin levels up to 59%; however, increased troponin levels are considered predictive of mortality.
Author Keywords: COVID-19, SARS-COV-2, Heart disease, Troponin.
Volume 39, Issue 3, May 2023, Pages 1340–1346
Hilmi Chorouk1, Kadouri Souhaila2, Asmaa Morjan3, and Kamal Nbiha4
1 Laboratoire de biochimie, CHU Ibn Rochd de Casablanca, Morocco
2 Laboratoire de biochimie, CHU Ibn Rochd de Casablanca, Morocco
3 Laboratoire de biochimie, CHU Ibn Rochd, Casablanca, Morocco
4 Laboratoire de biochimie, CHU Ibn Rochd de Casablanca, Morocco
Original language: French
Copyright © 2023 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
In December 2019 an infection with a new virus called SARS-COV2 emerged the Wuhan area in China and took the name of COVID-19 (Corona Virus Disease 2019). This disease has spread globally to the point of being called a pandemic by the WHO. Although mainly respiratory in nature, COVID-19 seems to trigger an intense inflammatory response, with a multi-systemic impact including the cardiovascular system. In this work, we propose to synthesize and analyze data from the literature to determine the usefulness of troponin measurement in patients with COVID-19. Cardiac troponin is a laboratory parameter and its measurement is relevant in the management of Covid-19 given the frequency of associated cardiovascular lesions. Several observational studies have shown that patients with Covid-19 have significant elevation of troponin levels up to 59%; however, increased troponin levels are considered predictive of mortality.
Author Keywords: COVID-19, SARS-COV-2, Heart disease, Troponin.
Abstract: (french)
En décembre 2019 une infection par un nouveau virus appelé SARS-COV2 a émergé la région de Wuhan en chine et a pris le nom de la COVID-19 (Corona Virus Disease 2019). Cette maladie s’est propagée à l’échelle mondiale au point d’être qualifiée par l’OMS de pandémie. Bien qu’ayant un tropisme principalement respiratoire, la COVID-19 semble déclencher une intense réaction inflammatoire, avec un impact multi systémique incluant notamment le système cardiovasculaire. Dans ce travail nous proposons de faire une synthèse par analyse des données de la littérature pour déterminer l’utilité du dosage de la troponine chez les patients atteints de la COVID-19. La troponine cardiaque est un paramètre de laboratoire son dosage s’avère pertinent dans la prise en charge de la Covid-19 vu la fréquence des lésions cardiovasculaires associées. Plusieurs études observationnelles ont montré que les patients atteints de la Covid-19 présentent une élévation importante des taux de la troponine pouvant atteindre 59%; cependant l’augmentation des taux de la troponine est considérée comme un facteur prédictif de mortalité.
Author Keywords: COVID-19, SARS-COV-2, Atteintes cardiaques, Troponine.
How to Cite this Article
Hilmi Chorouk, Kadouri Souhaila, Asmaa Morjan, and Kamal Nbiha, “The usefulness of troponin in patients with COVID19: Evidence from a meta-analysis,” International Journal of Innovation and Applied Studies, vol. 39, no. 3, pp. 1340–1346, May 2023.
